Advertisement

Canadian Anaesthetists’ Society Journal

, Volume 29, Issue 1, pp 35–41 | Cite as

Hypermagnesaemia and anaesthetic management

  • Michael N. Skaredoff
  • Edward R. Roaf
  • Sanjay Datta
Article

Abstract

The anaesthetic management of a pre-eclamptic parturient who was treated with high doses of magnesium sulphate and who developed hypermagnesaemia before delivery by Caesarean Section, is presented. The pharmacology of magnesium, particularly its effects at the neuromuscular junction, and clinical considerations of magnesium administration are discussed.

Key Words

COMPLICATIONS pre-eclampsia hypermagnesaemia PHARMACOLOGY magnesium 

Résumé

Les auteurs rapportent un cas d’apnée prolongée après administration de succinylcholine, chez une parturiente en pré-éclampsie et accouchée par césarienne; la patiente avait été traitée au sulfate de magnésie à doses élevées avant son intervention et présentait une hypermagnésémie. La pharmacologie du magnésium et, en particulier ses effets au niveau de la fonction neuro-musculaire ainsi que les applications cliniques de l’administration de cet agent sont discutés.

References

  1. 1.
    Weisberg, H.F. Water, electrolytes, acid-base, and oxygen, Todd-Sanford’s Clinical Diagnosis. 15th ed. Edited by I. Davidsohn and J.B. Henry. Philadelphia, Saunders (1974).Google Scholar
  2. 2.
    Keynes, W.M. The parathyroid glands. The Physiological Basis of Medical Practice. Edited by C.H. Best and N.B. Taylor. Baltimore, Williams & Wilkins (1966).Google Scholar
  3. 3.
    Sutherland, E.W. &Rall, T. W. The relation of adenosine 3’, 5’ phosphate and phosphorylase to the action of catecholamines and other hormones. Pharmacol. Rev.12: 265 (1960).Google Scholar
  4. 4.
    Hubbard, J.I. Mechanism of transmitter release. Prog. Biophys. Mol. Biol.21: 33 (1970).PubMedCrossRefGoogle Scholar
  5. 5.
    Katz, B. &Miledi, R. The localization of calcium action at the nerve muscle junction, J. Physiol. 1964;171: 10P (1964).Google Scholar
  6. 6.
    Katz, B. &Miledi, R. The effect of calcium on acetylcholine from motor nerve terminals. Proc. R. Soc. Lond. (Biol),161: 496 (1965).CrossRefGoogle Scholar
  7. 7.
    Katz, B. &Miledi, R. The timing of calcium action during neuromuscular transmission. J. Physiol.189: 535 (1967).PubMedGoogle Scholar
  8. 8.
    Kandel, E.R. Small systems of neurons. Scientific American241: 67 (1979).CrossRefGoogle Scholar
  9. 9.
    Dodge, F.A. &Rahamimoff, R. Co-operative action of calcium ions in transmitter release at the neuromuscular junction. J. Physiol.193: 419 (1967).PubMedGoogle Scholar
  10. 10.
    Colomo, F. &Rahamimoff, R. Interaction between sodium and calcium ions in the process of transmitter release at the neuromuscular junction. J. Physiol.198: 203 (1968).PubMedGoogle Scholar
  11. 11.
    del Castillo, J. &Engbaek, L. The nature of the neuromuscular block produced by magnesium. J. Physiol.124: 370 (1954).Google Scholar
  12. 12.
    Ghoneim, M. &Long, J. The interaction between magnesium and other neuromuscular blocking agents. Anesthesiology32: 23 (1970).PubMedCrossRefGoogle Scholar
  13. 13.
    Freeman, S.E. Ionic influences on succinylcholine blockade of the mammalian neuromuscular junction. Brit. J. Pharmacol.32: 546 (1968).PubMedGoogle Scholar
  14. 14.
    Katz, B. &Thesleff, S. A study of desensitization produced by acetylcholine at the motor endplate J. Physiol.138: 63 (1957).PubMedGoogle Scholar
  15. 15.
    Galindo, A. Depolarising neuromuscular block. J. Pharmacol. Exp. Ther.178: 339 (1971).PubMedGoogle Scholar
  16. 16.
    Galindo, A. The role of prejunctional effects in myoneural transmission. Anesthesiology36: 598 (1972).PubMedCrossRefGoogle Scholar
  17. 17.
    Feldman, S.A. &Tyrrell, M.F. A new theory on determination of action of the muscle relaxants. Proc. Roy. Soc. Med.63: 692 (1970).PubMedGoogle Scholar
  18. 18.
    Taylor, D.B., &Nedergaard, O.A. Relation between structure and action of quaternary amine neuromuscular blocking agents. Physiol. Rev.45: 523 (1965).PubMedGoogle Scholar
  19. 19.
    Rang, H.P., &Ritter, J.M. On the mechanism of densitization at cholinergic receptors. Mol. Pharmacol.6: 357 (1970).PubMedGoogle Scholar
  20. 20.
    Csul, J.F., Long, G.T., Brunner, E.A.,et al. The changing pattern of neuromuscular blockade caused by succinylcholine in man. Anesthesiology27: 729 (1966).Google Scholar
  21. 21.
    HäNze, S. Der Magnesiumstoffwechsel. Stuttgart, Georg Thieme Verlag (1962).Google Scholar
  22. 22.
    Loeb, J. On the different effect of ions upon myogenic and neurogenic rhythmical contractions and upon embryonic and muscular tissue. Am. J. Physiol.3: 383 (1900).Google Scholar
  23. 23.
    Perry, S.V. General Discussion - Phosphorylation and the regulation of contraction of smooth muscle.In: Casteels, R., Godfraind, T., Ruegg, T.E. eds. Excitation contraction complex in smooth muscle, Elsevier, Amsterdam (1977).Google Scholar
  24. 24.
    Weber, A. &Herz, R. The binding of calcium to actomyosin systems in relation to their biological activity. J. Biol. Chem.238: 599 (1963).PubMedGoogle Scholar
  25. 25.
    Yamamoto, T. The Ca2+-Mg+ dependent ATP-ase and the uptake of Ca2+ by the fragmented sarcoplasmic reticulum.In. Tonomura, Y., Takeshita, T. eds. Muscle, protein, muscle contractions and cation transport. Baltimore: Univ. Park Press (1974).Google Scholar
  26. 26.
    Daniel, E.E. Attempted synthesis of data regarding divalent ions in muscle junction.In: Paul, W.M., Daniel, E.E., Day, CM., Monckton, G. eds. Muscle. Oxford: Pergamon Press (1964).Google Scholar
  27. 27.
    Brink, F. The role of calcium in neural processes. Pharm. Rev.6: 243 (1964).Google Scholar
  28. 28.
    Szeckely, P. The action of magnesium on the heart. Br. Heart J.8: 115 (1946).CrossRefGoogle Scholar
  29. 29.
    Scher, A.M. Electrical Correlates of the Cardiac Cycle.In: Ruch, T. and Patton, H. eds. Physiology and Biophysics, Philadelphia: W.B. Saunders, (1960).Google Scholar
  30. 30.
    Rougier, 0., Vassort, G., Garnier, D.,et al. Existence and role of a slow inward current during the frog atrial action potential. Pflügers Arch Ges. Physiol.308: 91 (1969).CrossRefGoogle Scholar
  31. 31.
    Mascher, D., &Peper, K. TWO COMPONENTS OF INWARD CURRENT IN MYOCARDIAL MUSCLE FIBERS. Pflügers Arch Ges. Physiol.307: 190 (1969).CrossRefGoogle Scholar
  32. 32.
    Garnier, D., Rougier, O., Gargouil, Y.M.,et al. Analyse électrophysiologique du plateau des réponses myocardiques mis en evidence d’un courant entrant en absence d’ions bivalents. Pflügers Arch Ges. Physiol.313: 321 (1969).CrossRefGoogle Scholar
  33. 33.
    Chesnais, J.M., Coraboeuf, E., Sanvial, M.P.,et al. Inhibition par les ions magnésium de la conductance sodique lente apparaissant sous l’effet des dépolarisation membranaires au niveau des fibres atriales de grenouille. Comptes-Rendues Acad. Sci. (D) (Paris)273: 1594 (1971).Google Scholar
  34. 34.
    Siefen, E. Dependency on Mg- and Ca-concentration of cycle length in spontaneously beating guinea-pig atria. Pflügers Arch Ges. Physiol.304: 46 (1968).CrossRefGoogle Scholar
  35. 35.
    Hashimoto, K., Suzuki, Y. &Chiba, S. Influence of calcium and magnesium ions on the sino-atrial node pacemaker activity of the canine heart. Tohoku J. Exp. Med.113: 187 (1974).PubMedCrossRefGoogle Scholar
  36. 36.
    Reiter, M. &Noe, J. DIE BEDEUTUNG VON CA, MG, K UND NA FüR DIE SYNTHETISCHE ERREGUNGSBILDUNG IN SINUSKNOTEN DES WARMBLüTERHERZENS. Pflügers Arch Ges. Physiol.269: 366 (1959).CrossRefGoogle Scholar
  37. 37.
    Woods, W.T., Katholi, R.E., Urthuler, F.,et al. Electrophysiological effects of magnesium on cells in the canine sinus node and false tendon. Circ. Res.44: 182 (1979).PubMedGoogle Scholar
  38. 38.
    Chadda, H.D., Lichstein, E. &Gupta, P. Hypomagnesemia and refactory cardiac arrhythmias in a non-digitalized patient. Amer. J. Cardiol.31: 98 (1973).PubMedCrossRefGoogle Scholar
  39. 39.
    Kim, Y.W., Andrews, C.L. &Ruth, W.L. Serum magnesium and cardiac arrhythmias with special reference to digitalis intoxication. Am. J. Med. Sci.242: 87 (1961).PubMedCrossRefGoogle Scholar
  40. 40.
    Loeb, H.S., Pietras, R.P., Gunnar, R.M.,et al. Paroxysmal ventricular fibrillation in two patients with hypomagnesemia. Circulation37: 210 (1968).Google Scholar
  41. 41.
    Van Dyke, H.B. &Hastings, A.B. The response of smooth muscle in different ionic environments. Am. J. Physiol.83: 563 (1928).Google Scholar
  42. 42.
    Genell, S. Die Bedeutung des Magnesiumions für die Motorik des überlebenden Uterus. Skandinav. Arch. f. Physiol.80: 124 (1938).Google Scholar
  43. 43.
    Fraser, A.M. Effect of magnesium on response of uterus Io posterior pituitary hormones. J. Pharm. Exp. Ther.66: 85 (1939).Google Scholar
  44. 44.
    Wodon, J.L. Sur l’abolition de la téntanisation utérine par les sels magnésiques. Compt. Rend. Soc. de Biol.103: 529 (1929).Google Scholar
  45. 45.
    Wodon, J.L. De l’abolition des sels magnésiques de la contraction utérine obtenue par divers agents tétanisants. Compt. Rend. Soc. de Biol.103: 930 (1929).Google Scholar
  46. 46.
    Labarre, J., &Wodon, J.L. Démonstrationin vivo de l’action decontracturant du sulfate magnésique sur uterus tétanisé par l’extrait posthypophysaire. Compt. Rend. Soc. de Biol.103: 531 (1929).Google Scholar
  47. 47.
    Abarbanel, A.R. The spasmolysant action of magnesium ions on the tetanically contracting human gravid uterus. Am. J. Obstet. Gynecol.49: 473 (1945).Google Scholar
  48. 48.
    Hutchison, H.T., Nichols, M.M., Kuhn, C.R.,et al. Effects of magnesium sulfate on uterine contractility, intrauterine fetus and infant. Am. J. Obstet. Gynecol.88: 747 (1964).Google Scholar
  49. 49.
    Peck, C.H. &Meltzer, S.J. Anesthesia in human beings by intravenous injection of magnesium sulphate J. A.M. A.68: 1131 (1916).Google Scholar
  50. 50.
    Somjen, G., Milmy, M. &Stephen, C.R. Failure to anesthetize human subjects by intravenous administration of magnesium sulfate. J. Pharm. Exp. Ther.154: 652 (1966).Google Scholar
  51. 51.
    Aldrete, J.A., Barnes, D.R. &Aikawa, J.K. Does magnesium produce anesthesia? Evaluation of its effects on the cardiovascular and neurologic systems. Anes. Anaig. (Cleve.)47: 428 (1968).Google Scholar
  52. 52.
    Jones, J.E., Desper, P.C., Shane, S.R.,et al. Magnesium metabolism in hyperthyroidism and hypothyroidism. J. Clin. Invest.45: 891 (1966).PubMedCrossRefGoogle Scholar
  53. 53.
    Wacker, W.E.C. Magnesium, in: Mineral Metabolism: An advanced treatise: Vol. 2, The elements, Parts A-B, Part A. Edited by C.L. Cornar and F. Bronner. New York, Academic Press (1964).Google Scholar
  54. 54.
    Robinson, R.R., Murdugh, H.V. &Peschel, E. Renal factors responsible for hypermagnesium of renal disease. J. Lab. & Clin. Med.53: 572 (1959).Google Scholar
  55. 55.
    Randall, R.E., Cohen, M.D., Spray, C.C.et al. Hypermagnesemia in renal failure: Etiology and toxic manifestations. Ann. Int. Med.61: 73 (1964).PubMedGoogle Scholar
  56. 56.
    Wacker, W.E.C. &Parisi, A. Magnesium metabolism. N. Eng. J. Med.278: 658, 712, 772 (1968).CrossRefGoogle Scholar
  57. 57.
    Shelly, W.C. &Gutsche, B.B. Magnesium and seizure control. Am. J. Obstet. Gynec.136: 146 (1980).Google Scholar
  58. 58.
    Hibbard, B.J. &Rosen, M. The management of severe pre-eclampsia and eclampsia. Br. J. Anaesth.49: 3 (1977).PubMedCrossRefGoogle Scholar
  59. 59.
    Borges, L.F. &Gucer, G. Effect of magnesium on epileptic foci. Epilepsia19: 81 (1978).PubMedGoogle Scholar
  60. 60.
    Chesley, L.C. &Tepper, I. Plasma levels of magnesium attained in magnesium sulfate therapy for pre-eclampsia and eclampsia. Surg. Clin. N. Amer.353 April (1957).Google Scholar
  61. 61.
    Harbert, G.M., Cornell, G.W. &Thornton, W.N. Effect of toxemia therapy on hemodynamics. Am. J. Obstet. Gynec.105: 94 (1969).PubMedGoogle Scholar
  62. 62.
    Mccall, M.L. &Sass, D. The action of magnesium sulfate on cerebral circulation and metabolism in toxemia of pregnancy. Am. J. Obstet. Gynec.71: 1089 (1956).PubMedGoogle Scholar
  63. 63.
    Eisenbut, E. &Lobue, C. Hypocalcemia after therapeutic use of magnesium sulfate. Arch. Int. Med.136: 688 (1976).CrossRefGoogle Scholar
  64. 64.
    Pritchard, J. &Pritchard, S. Standardized treatment of 154 consecutive cases of eclampsia. Am. J. Obstet. Gynec.123: 543 (1975).PubMedGoogle Scholar
  65. 65.
    Chesley, L.C. Hypertensive Disorders in Pregnancy. New York, Appelton-Century-Crofts (1975).Google Scholar
  66. 66.
    Morris, R. &Giesecke, A. Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy. So. Med. J.61: 25 (1968).CrossRefGoogle Scholar
  67. 67.
    Giesecke, A.H., Morris, R.E., Dalton, M.D.,et al. Of magnesium muscle relaxants, toxemic parturients and cats. Anes. Analg. (Cleve.)47: 689 (1968).Google Scholar

Copyright information

© Canadian Anesthesiologists 1982

Authors and Affiliations

  • Michael N. Skaredoff
    • 1
  • Edward R. Roaf
    • 1
  • Sanjay Datta
    • 1
  1. 1.Harvard Medical School and Department of AnaesthesiaThe Brigham and Women’s HospitalBostonUSA

Personalised recommendations